|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO, USA
* To whom correspondence should be addressed. E-mail: richesd{at}njc.org.
Idiopathic pulmonary fibrosis (IPF) is an insidious lung disease with no known cure or effective therapy. Macrophage-derived insulin-like growth factor-I (IGF-I) is thought to play a role in the pathogenesis of IPF, however, little is known about the control of IGF-I expression in macrophages. In this report we investigated the cisregulatory elements that control basal expression using luciferase reporter constructs in RAW264.7 macrophages. We show that the +95 to +329 region contains elements necessary to direct maximal promoter activity whereas the +251 to +329 region contains the minimal promoter. Mapping transcriptional start sites for endogenous IGF-I in primary macrophages revealed that the major transcriptional start site is centered at +150 whereas the most 3'transcriptional start site is centered at +255. Nuclear proteins from primary and RAW264.7 macrophages bind specifically to the region required for maximal promoter activity (+134 to +173) and to the region required for minimal promoter activity (+267 to +299). Antibody supershift assays indicate that Sp3 bound to the +267 to +299 region. Moreover, mutation of the putative binding site reduced Sp3 binding in EMSAs and increased promoter activity in luciferase reporter gene assays. We also found that the regions from -1711 to -855 and -855 to -337 contain putative macrophage specific suppressor elements that do not function in HeLa or Cos-7 epithelial cell lines. These data support the view that macrophage IGF-I expression is positively regulated by elements located in the 5'-untranslated region and negatively regulated by elements in the 5'-flanking region of the IGF-I gene.
This article has been cited by other articles:
![]() |
R. Telgmann, C. Dordelmann, E. Brand, V. Nicaud, C. Hagedorn, H. Pavenstadt, F. Cambien, L. Tiret, M. Paul, and S.-M. Brand-Herrmann Molecular genetic analysis of a human insulin-like growth factor 1 promoter P1 variation FASEB J, May 1, 2009; 23(5): 1303 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sukhanov, Y. Higashi, S.-Y. Shai, C. Vaughn, J. Mohler, Y. Li, Y.-H. Song, J. Titterington, and P. Delafontaine IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2684 - 2690. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |